Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01376895 · ClinicalTrials.gov registry record · Phase 1
Project Power: An HIV Risk Reduction Intervention for Black Men Who Have Sex With Men and Women (BMSM/W)
A Phase 1 study, sponsored by Nova Southeastern University.
- Completed
- Registry status
- Phase 1
- Development phase
- 211
- Enrollment target
NCT01376895: Completed Phase 1 study, sponsored by Nova Southeastern University.
NCT01376895 is a Phase 1 study that has completed, run by Nova Southeastern University. The registered enrollment target is 211 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (252% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01376895, a Phase 1 study, has completed, sponsored by Nova Southeastern University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 211 participants
- Enrollment target
Study Summary
The goal of this study is to develop and test a program to help Black men who have sex with men and women reduce their chances of getting or giving HIV infection to their sex partners. The program is designed to be delivered via the internet so that it would be available to more men. Men who agree to participate in the study will be assigned by chance to receive the POWER intervention or a similar program that is focused on general health called POWER-HEALTH. They will also complete a computer administered interview when they first enroll in the study, 2 weeks following the last session of the program and 3 months after that. Participants will receive a small compensation for their time and effort.
Primary Outcome
Unprotected sex refers to either vaginal or anal sex
Interventions
- BEHAVIORAL PROJECT POWER
- BEHAVIORAL Power Health
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2011-07 |
| Est. Completion | 2014-03 |
| Phase | Phase 1 |
What the finished NCT01376895 record still lists
NCT01376895 is an interventional study that assigns participants to a tested intervention. The registered 211 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (252% higher).
The record links to 0 conditions, and to 2 interventions - of which PROJECT POWER is the first listed.
NCT01376895 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01376895 about?
NCT01376895 is a clinical study titled "Project Power: An HIV Risk Reduction Intervention for Black Men Who Have Sex With Men and Women (BMSM/W)". The goal of this study is to develop and test a program to help Black men who have sex with men and women reduce their chances of getting or giving HIV infection to their sex partners. The program is designed to be delivered via the internet so that it would be available to more men. Men who agree t...
What is the current status of trial NCT01376895?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 211 participants. The study started on 2011-07. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01376895?
The interventions under investigation include: PROJECT POWER (BEHAVIORAL), Power Health (BEHAVIORAL).
Who is sponsoring clinical trial NCT01376895?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01376895's enrollment target sits among peer trials
211 245th of 2000 higher than 1,756 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06698796 · 211 participants · Phase 3
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia